Nora is broadly interested in identifying shared factors of depression and anxiety that influence treatment response, as well as psychotherapeutic mechanisms of change. In turn, she hopes to use this knowledge to inform treatment selection and personalization approaches to more effectively treat these disorders.
Brett wants to develop more precise, adaptive, and valid measures of symptoms relevant to depression and anxiety disorders. He, in turn, is interested in how these measures can help to select and personalize treatments to better serve individual needs.
Kristen is interested in examining how early experiences contribute to emotion regulation and processing across the lifespan, and how they can alter subsequent risk for depression and anxiety. She hopes to study mechanisms that underlie risk for and development of anxiety and depression as well as the translation of this work towards neuroscience-informed interventions addressing these disorders.
Kaylee is interested in individual differences in the neural, cognitive, and affective mechanisms underlying internalizing disorders. She is further interested in the impact of stress on emotion regulation and reward processing in depression and anxiety. She hopes such work may be used to inform novel, personalized treatment approaches.
Christina is interested in determining markers and mechanisms of illness trajectory within mood and anxiety disorders. This includes neural, cognitive, and peripheral (e.g. immune and hormonal) correlates and predictors of disease development, course, and symptomatology, along with a particular interest in treatment response. It is her hope that this work may facilitate the development and improvement of mechanistically-based risk factors, treatments, and other intervention strategies.
Olivia is interested in using intra-individual and temporal data (such as ecological momentary assessment) to better understand the mechanisms underlying anxiety and related disorders and treatment. She is also interested in how social interactions impact anxiety symptoms.
Allison is interested in risk and resilience factors for depression and anxiety with the aim of improving prevention efforts and interventions for these disorders. Within this lens, she is specifically interested in how social factors affect one’s emotion regulation and how this together predicts symptoms and associated functional impairment.
Ben’s interests lie at the intersection of cognitive neuroscience and clinical psychology. He utilizes multimodal neuroimaging tools such as MRI and TMS to develop strategies for 1) clarifying the dynamics of human brain network architecture, 2) disentangling the neurodevelopmental underpinnings of clinical symptoms, and 3) evaluating neurocognitive biomarkers to improve diagnostic classification.
Chrissy is interested in understanding the cognitive, affective, and neural underpinnings of anxiety and mood disorders with the aim of enhancing treatments. She is also interested in emotion regulation and positive emotion.
Julia is broadly interested in risk for and treatment of depression, anxiety, and suicide ideation. Specifically, she studies emotional, cognitive, and health-related risk factors for these conditions, as well as novel and personalized treatments. She is also interested in dimensional, rather than categorical, models of psychopathology given their more precise representation of symptom manifestation.
Nora is broadly interested in identifying shared factors of depression and anxiety that influence treatment response, as well as psychotherapeutic mechanisms of change. In turn, she hopes to use this knowledge to inform treatment selection and personalization approaches to more effectively treat these disorders.
Brett wants to develop more precise, adaptive, and valid measures of symptoms relevant to depression and anxiety disorders. He, in turn, is interested in how these measures can help to select and personalize treatments to better serve individual needs.
Kristen is interested in examining how early experiences contribute to emotion regulation and processing across the lifespan, and how they can alter subsequent risk for depression and anxiety. She hopes to study mechanisms that underlie risk for and development of anxiety and depression as well as the translation of this work towards neuroscience-informed interventions addressing these disorders.
Kaylee is interested in individual differences in the neural, cognitive, and affective mechanisms underlying internalizing disorders. She is further interested in the impact of stress on emotion regulation and reward processing in depression and anxiety. She hopes such work may be used to inform novel, personalized treatment approaches. 
Christina is interested in determining markers and mechanisms of illness trajectory within mood and anxiety disorders. This includes neural, cognitive, and peripheral (e.g. immune and hormonal) correlates and predictors of disease development, course, and symptomatology, along with a particular interest in treatment response. It is her hope that this work may facilitate the development and improvement of mechanistically-based risk factors, treatments, and other intervention strategies.
Olivia is interested in using intra-individual and temporal data (such as ecological momentary assessment) to better understand the mechanisms underlying anxiety and related disorders and treatment. She is also interested in how social interactions impact anxiety symptoms.
Allison is interested in risk and resilience factors for depression and anxiety with the aim of improving prevention efforts and interventions for these disorders. Within this lens, she is specifically interested in how social factors affect one’s emotion regulation and how this together predicts symptoms and associated functional impairment.
Ben’s interests lie at the intersection of cognitive neuroscience and clinical psychology. He utilizes multimodal neuroimaging tools such as MRI and TMS to develop strategies for 1) clarifying the dynamics of human brain network architecture, 2) disentangling the neurodevelopmental underpinnings of clinical symptoms, and 3) evaluating neurocognitive biomarkers to improve diagnostic classification.
Chrissy is interested in understanding the cognitive, affective, and neural underpinnings of anxiety and mood disorders with the aim of enhancing treatments. She is also interested in emotion regulation and positive emotion.